Tabac pour pipe à eau : Questions médicales fréquentes
Nom anglais: Tobacco, Waterpipe
Descriptor UI:D000073846
Tree Number:J01.637.767.844.750
Termes MeSH sélectionnés :
Tilt-Table Test
Questions fréquentes et termes MeSH associés
Diagnostic
2
#1
Comment diagnostiquer une dépendance au tabac à pipe à eau ?
Un diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de sevrage.
Dépendance au tabacDiagnostic médical
#2
Quels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?
Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets sur la santé.
Fonction pulmonaireTests diagnostiques
Symptômes
2
#1
Quels sont les symptômes d'une consommation excessive ?
Les symptômes incluent toux, essoufflement, fatigue et irritation des voies respiratoires.
TouxEssoufflement
#2
Comment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?
Il peut causer des maladies des gencives, des caries et des taches sur les dents.
Santé bucco-dentaireMaladies des gencives
Prévention
2
#1
Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?
L'éducation sur les risques et la promotion d'activités alternatives sont essentielles.
Prévention du tabagismeÉducation à la santé
#2
Quelles campagnes sont efficaces contre le tabac à pipe à eau ?
Les campagnes de sensibilisation et les restrictions publicitaires montrent des résultats positifs.
Campagnes de santé publiqueTabagisme
Traitements
2
#1
Quels traitements existent pour arrêter le tabac à pipe à eau ?
Les traitements incluent les thérapies comportementales et les substituts nicotiniques.
Thérapie comportementaleSubstituts nicotiniques
#2
Les médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?
Oui, des médicaments comme la varénicline peuvent réduire les envies de fumer.
VaréniclineMédicaments anti-tabac
Complications
2
#1
Quelles sont les complications respiratoires liées au tabac à pipe à eau ?
Les complications incluent bronchite chronique, emphysème et risque accru de cancer du poumon.
Bronchite chroniqueCancer du poumon
#2
Le tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?
Oui, il augmente le risque de maladies cardiovasculaires en affectant la circulation sanguine.
Maladies cardiovasculairesCirculation sanguine
Facteurs de risque
2
#1
Quels sont les principaux facteurs de risque du tabac à pipe à eau ?
Les facteurs incluent l'âge, le milieu social, et l'exposition à d'autres fumeurs.
Facteurs de risqueTabagisme
#2
Les femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?
Oui, cela peut nuire au développement fœtal et augmenter les complications de grossesse.
GrossesseTabagisme
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tabac pour pipe à eau : Questions médicales les plus fréquentes",
"headline": "Tabac pour pipe à eau : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tabac pour pipe à eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-20",
"dateModified": "2025-05-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tabac pour pipe à eau"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Produits du tabac",
"url": "https://questionsmedicales.fr/mesh/D062789",
"about": {
"@type": "MedicalCondition",
"name": "Produits du tabac",
"code": {
"@type": "MedicalCode",
"code": "D062789",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767.844"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tabac pour pipe à eau",
"alternateName": "Tobacco, Waterpipe",
"code": {
"@type": "MedicalCode",
"code": "D000073846",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Omar F Khabour",
"url": "https://questionsmedicales.fr/author/Omar%20F%20Khabour",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Applied Medical Sciences, Department of Laboratory Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan."
}
},
{
"@type": "Person",
"name": "Karem H Alzoubi",
"url": "https://questionsmedicales.fr/author/Karem%20H%20Alzoubi",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan."
}
},
{
"@type": "Person",
"name": "Erin L Sutfin",
"url": "https://questionsmedicales.fr/author/Erin%20L%20Sutfin",
"affiliation": {
"@type": "Organization",
"name": "Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA esutfin@wakehealth.edu."
}
},
{
"@type": "Person",
"name": "Jennifer Cornacchione Ross",
"url": "https://questionsmedicales.fr/author/Jennifer%20Cornacchione%20Ross",
"affiliation": {
"@type": "Organization",
"name": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA."
}
},
{
"@type": "Person",
"name": "Thomas Eissenberg",
"url": "https://questionsmedicales.fr/author/Thomas%20Eissenberg",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, Virginia Commonwealth University, Richmond, VA, United States of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Tilt testing.",
"datePublished": "2023-11-23",
"url": "https://questionsmedicales.fr/article/37726165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/pn-2023-003749"
}
},
{
"@type": "ScholarlyArticle",
"name": "Syncope without prodromes is associated with excessive plasma release of adenosine at the time of syncope during head-up tilt table test.",
"datePublished": "2022-06-16",
"url": "https://questionsmedicales.fr/article/35716941",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijcard.2022.06.045"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dynamic ST-segment elevation during head-up tilt test.",
"datePublished": "2022-12-09",
"url": "https://questionsmedicales.fr/article/36484708",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/anec.13029"
}
},
{
"@type": "ScholarlyArticle",
"name": "The clinical presentation of syncope influences the head-up tilt test responses.",
"datePublished": "2023-01-11",
"url": "https://questionsmedicales.fr/article/36639324",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejim.2023.01.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tilt table testing, methodology and practical insights for the clinic.",
"datePublished": "2023-10-15",
"url": "https://questionsmedicales.fr/article/37839043",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cpf.12859"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits manufacturés",
"item": "https://questionsmedicales.fr/mesh/D008420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Dispositifs pour fumer",
"item": "https://questionsmedicales.fr/mesh/D000074602"
},
{
"@type": "ListItem",
"position": 5,
"name": "Produits du tabac",
"item": "https://questionsmedicales.fr/mesh/D062789"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tabac pour pipe à eau",
"item": "https://questionsmedicales.fr/mesh/D000073846"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tabac pour pipe à eau - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tabac pour pipe à eau",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tabac pour pipe à eau",
"description": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?\nQuels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Tilt-Table+Test#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tabac pour pipe à eau",
"description": "Quels sont les symptômes d'une consommation excessive ?\nComment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Tilt-Table+Test#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tabac pour pipe à eau",
"description": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?\nQuelles campagnes sont efficaces contre le tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Tilt-Table+Test#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tabac pour pipe à eau",
"description": "Quels traitements existent pour arrêter le tabac à pipe à eau ?\nLes médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Tilt-Table+Test#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tabac pour pipe à eau",
"description": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?\nLe tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Tilt-Table+Test#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tabac pour pipe à eau",
"description": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?\nLes femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Tilt-Table+Test#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets sur la santé."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une consommation excessive ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, essoufflement, fatigue et irritation des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Comment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut causer des maladies des gencives, des caries et des taches sur les dents."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sur les risques et la promotion d'activités alternatives sont essentielles."
}
},
{
"@type": "Question",
"name": "Quelles campagnes sont efficaces contre le tabac à pipe à eau ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de sensibilisation et les restrictions publicitaires montrent des résultats positifs."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour arrêter le tabac à pipe à eau ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les thérapies comportementales et les substituts nicotiniques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme la varénicline peuvent réduire les envies de fumer."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent bronchite chronique, emphysème et risque accru de cancer du poumon."
}
},
{
"@type": "Question",
"name": "Le tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il augmente le risque de maladies cardiovasculaires en affectant la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le milieu social, et l'exposition à d'autres fumeurs."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cela peut nuire au développement fœtal et augmenter les complications de grossesse."
}
}
]
}
]
}
Mohammed Moumen, Medical Student, Wake Forrest School of Medicine, Winston-Salem, NC. Marielle Brinkman, Senior Research Scientist, Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH. Brittney Keller-Hamilton, Research Scientist, Comprehensive Cancer Center, The Ohio State University, Columbus, OH. Andreas A. Teferra, Doctoral Student, Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH. Megan E. Roberts, Assistant Professor, Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH. Elizabeth G. Klein, Interim Chair and Associate Professor, Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH. Paul Nini, Professor, Department of Design, College of Arts and Sciences, The Ohio State University, Columbus, OH. Michael Pennell, Associate Professor, Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH. Amy K. Ferketich, Professor Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH.
Department of Internal Medicine, The Ohio State University College of Medicine, Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America.
Department of Internal Medicine, The Ohio State University College of Medicine, Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America.
Tilt testing can help to diagnose unexplained syncope, by precipitating an episode during cardiac monitoring. The Italian protocol, now most widely used, involves giving sublingual nitroglycerine afte...
In syncopal patients without underlying structural disease, we sought to investigate the association of Adenosine Plasma Levels (ADP) with the clinical presentation of neurally mediated syncope (NMS) ...
We studied 124 patients with different clinical types of NMS, i.e., Vasovagal (VVS, n=58), non-prodromes (NPS, n=18), or situational syncope (SS, n=48), using a standard protocol including HUTT and AD...
Baseline ADP did not differ among groups. ADP at syncope were higher in NPS (n=5) compared to VVS (n=20): 0.23 vs. 0.12 μΜ, p=0.03, and SS (n=22): 0.04 μΜ, p=0.02. In NPS, ADP increased from supine to...
The subset of NPS patients with positive HUTT, show excessive ADP release at the time of syncope. This may explain the lack of prodromes in this form of syncope. Such observations contribute to the un...
Little is still known about the positivity rate of nitroglycerin (NTG) potentiated head-up tilt test (HUTT) according to the history-based clinical features of syncope. The study aimed to compare the ...
We retrospectively evaluated all consecutive patients who underwent NTG-potentiated HUTT for VVS. The study population was dichotomized into classical and non-classical VVS....
A total of 1285 VVS patients (45± 19.1 years; 49.6% male) were enrolled: 627 (48.8%) had a history of classical VVS and 658 (51.2%) of non-classical VVS. HUTT was positive in 866 (67.4%) patients. The...
The clinical presentation of syncope influences the overall HUTT positivity rate and the type of responses. Cardioinhibitory response and traumatic syncope are more likely in patients with non-classic...
Tilt table testing (TTT) has been used for decades to study short-term blood pressure (BP) and heart rate regulation during orthostatic challenges. TTT provokes vasovagal reflex in many syncope patien...
To assess the recovery of the cardiac autonomic control system (CACS) response to the modified tilt-test during rehabilitation, in children post moderate-severe TBI at the subacute phase post-injury....
Thirty-seven children aged 6-18 years, 14-162 days post moderate-severe TBI, participated in the study. The assessment included CACS values evaluation (heart rate (HR), heart rate variability (HRV) an...
In both assessments, only four children reported symptoms associated with orthostatic intolerance during the modified tilt-test. No change was found over time in the HR and HRV values at rest. In resp...
Children post moderate-severe TBI at the sub-acute phase post-injury, have a better systolic blood pressure response during the modified tilt-test after eight weeks of individually tailored rehabilita...
NCT03215082....
Although beta blockers, such as metoprolol, have been widely used in the management of vasovagal syncope (VVS), their efficacy remains debated, with larger studies showing limited benefit. Identifying...
This retrospective study was conducted at a single center. Patients diagnosed with VVS and treated with metoprolol for a minimum of three months were included. A 50% reduction in syncope symptom score...
A total of 168 VVS patients were enrolled between January 2016 and December 2020. Of these, 100 patients responded positively to metoprolol, while 68 did not. No significant differences in baseline ch...
Higher peak HR, larger increases in HR, and greater HR variability during the HUTT may serve as reliable predictors of a positive response to metoprolol in patients with VVS....
In the pediatric population, syncope is mainly from vasovagal (VVS) origin. Its evaluation must be done by clinical methods, and the tilt test (TT) can contribute to the diagnosis....
To analyze the clinical profile, Calgary and modified Calgary scores, response to TT and heart rate variability (HRV) of patients aged ≤ 18 years with presumed VVS. To compare the variables between pa...
Observational and prospective study, with 73 patients aged between 6 and 18 years, submitted to clinical evaluation and calculation of scores without previous knowledge of the TT. It was done at 70º u...
Median age was 14.0 years; 52% of participants were female, 72 had Calgary ≥ -2 (mean 1.80), and 69 had modified Calgary ≥ -3 (mean 1.38). Prodromes were observed in 59 patients, recurrence in 50 and ...
Most children and adolescents with a presumed diagnosis of VVS presented a typical clinical scenario, with a Calgary score ≥ -2, and a predominant vasodepressor response to TT. Greater sympathetic act...
Head-up tilt test (HUTT) is clinically advantageous for diagnosing patients with vasovagal syncope (VVS). Nitroglycerin is mainly used as a stimulant during HUTT, and mitochondrial aldehyde dehydrogen...
A total of 199 VVS patients were enrolled, including 101 patients in the ALDH2*1/*1 group and 98 patients in the ALDH2*2 group. Among patients undergoing HUTT-NTG, 70.3% of patients in the ALDH2*1/*1 ...
ALDH2 Glu487Lys polymorphism did not affect the outcome of VVS patients undergoing HUTT-NTG, and no significant change in the hemodynamic characteristics of different genotypes was found....
Otolith organ acts complementarily with the autonomic nervous system to maintain blood pressure. However, the effect of blood pressure variability in the autonomic nervous system on otolith organ has ...
This study included 432 patients diagnosed with idiopathic BPPV. The follow-up period for all patients was 12 months. Age, sex, hypertension, diabetes and recurrence were analyzed. The HUTT parameters...
In summary, the group with increased average diastolic blood pressure (DBP1) showed a higher tendency for BPPV recurrence compared to the group with decreased diastolic blood pressure (DBP2) in the up...
It is presumed that poor autonomic nervous system response through vestibulosympathetic reflex maintains elevated diastolic blood pressure in the upright position during the HUTT. This variability is ...